Showing results (961-970 of 4,560) with videos related to
Sort By:
Pageof 456
Neuropsychiatric Disease and Treatment|October 24, 2025
Effects of Melatonin Disorders on Parkinson's Disease: A Review of Mechanisms and Clinical ManifestationsYiwei Shen, Cong He, Yulin Wang, et al.Neuropsychiatric Disease and Treatment|October 13, 2025
Oxidative Imbalance in Conversion Disorder: Evidence from Thiol-Disulphide Homeostasis DisruptionHasan Büyükaslan, Mehmet Asoğlu, Mustafa Sever, et al.Neuropsychiatric Disease and Treatment|June 18, 2020
HMGB1/CXCL12-Mediated Immunity and Th17 Cells Might Underlie Highly Suspected Autoimmune Epilepsy in Elderly IndividualsYuxiang Han, Liling Yang, Xiaoyun Liu, et al.Neuropsychiatric Disease and Treatment|September 15, 2021
Association Between Anxious Symptom Severity and Olfactory Impairment in Young Adults with Generalized Anxiety Disorder: A Case-Control StudyXiacan Chen, Wanjun Guo, Liangming Yu, et al.Neuropsychiatric Disease and Treatment|September 16, 2021
An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I DisorderLeslie Citrome, Christine Graham, Adam Simmons, et al.Neuropsychiatric Disease and Treatment|October 22, 2019
Diffusion Tensor Imaging And Tractography In Autistic, Dysphasic, And Healthy Control ChildrenMichal Hrdlicka, Jan Sanda, Tomas Urbanek, et al.Neuropsychiatric Disease and Treatment|October 22, 2019
Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson's Disease And SchizophreniaAshish Kumar Gupta, Ruchika Pokhriyal, Mohd Imran Khan, et al.Neuropsychiatric Disease and Treatment|October 22, 2019
Is Autism Inborn And Lifelong For Everyone?Paul Whiteley, Kevin Carr, Paul ShattockNeuropsychiatric Disease and Treatment|October 22, 2019
Erratum: Bipolar Spectrum Disorders And Associated Factors Among Adults Attending An Antiretroviral Therapy Clinic In Gedeo Zone Health Centers, Southern Ethiopia [Corrigendum]Neuropsychiatric Disease and Treatment|October 22, 2019
CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis PatientsYou-Ting Lin, Xue Yang, Jing-Wei Lv, et al.Pageof 456